Work & Mother has opened its latest location in downtown Houston. Photo courtesy of Work & Mother

As companies roll out back-to-work plans for the new year, one subset of workers' needs might be overlooked: new, breastfeeding mothers. However, one Houston startups is looking out for them with a new downtown location.

Work & Mother Services LLC creates and manages a suite of breastfeeding rooms and support equipment — along with a booking smartphone app, and has officially opened its new suite at Three Allen Center. The new facility has 10 private rooms, each equipped with a hospital grade pump, milk storage bags and other supplies; cleaning and sanitizing stations; lockers; refrigeration options; and more.

Work & Mother takes a professional and spa-like approach to a daily, usually dreaded task new moms take on, while also allowing the employer a chance to provide its employees a necessary amenity.

"Pumping at work has always been incredibly hard for mothers. Now, with the pandemic, there are the added complications of germ spread, closed community spaces, and repurposed wellness rooms, which makes pumping at work nearly impossible. Yet, most employers still have a legal obligation to provide a proper space for nursing mothers," says Abbey Donnell, founder and CEO of Work & Mother, in a news release.

Per the Fair Labor Standards Act Section 7(r), companies with 50 or more employees are required to provide "a place, other than a bathroom, that is shielded from view and free from intrusion from coworkers and the public, which may be used by an employee to express breast milk." Companies that aren't in compliance with Section 7(r) — and lack the resources to do so — can either purchase individual or company memberships to Work & Mother.

Brookfield Properties, which is the management company over Allen Center, has now helped its tenants have access to a facility that will help them be compliant.

"Brookfield Properties is deeply committed to creating highly amenitized work environments for our tenants," says Travis Overall, executive vice president and head of the Texas Region for Brookfield Properties. "We have a strong presence of working mothers at the Allen Center campus, which requires thoughtfully curated wellness amenities, such as Work & Mother. We look forward to having this valuable resource readily available for our working mothers once it opens."

Work & Mother has opened other locations downtown, including one at 712 Main St., but the new location at Three Allen Center, designed by PDR Corp., is the latest.

"It's been a great experience to partner with Brookfield Properties on this project, it's clear that they truly care about their tenants. The space at Allen Center is a beautiful, professional amenity that enables working mothers of the buildings and surrounding area to pump safely and with dignity," says Donnell.

Next year, Work & Mother plans to open its first non-Houston location in Austin.

Private rooms

Photo courtesy of Work & Mother

The new facility in Three Allen Center has 10 private rooms, and mothers can book on the Work & Mother app.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.